Serum uric acid level predicts adverse outcomes after myocardial revascularization or cardiac valve surgery
European Journal of Preventive Cardiology

Abstract
High levels of serum uric acid have been associated with adverse outcomes in cardiovascular diseases such as myocardial infarction and heart failure. The aim of the current study was to evaluate the prognostic role of serum uric acid levels in patients undergoing cardiac rehabilitation after myocardial revascularization and/or cardiac valve surgery.
We performed an observational prospective cohort study.
The study included 1440 patients with available serum uric acid levels, prospectively followed for 50 ± 17 months. Mean age was 67 ± 11 years; 781 patients (54%) underwent myocardial revascularization, 474 (33%) cardiac valve surgery and 185 (13%) valve-plus-coronary artery by-pass graft surgery. The primary endpoints were overall and cardiovascular mortality while secondary end-points were combined major adverse cardiac and cerebrovascular events.
Serum uric acid level mean values were 286 ± 95 µmol/l and elevated serum uric acid levels (≥360 µmol/l or 6 mg/dl) were found in 275 patients (19%). Overall mortality (hazard ratio = 2.1; 95% confidence interval: 1.5–3.0;
Serum uric acid levels predict mortality and adverse cardiovascular outcome in patients undergoing myocardial revascularization and/or cardiac valve surgery even after the adjustment for age, gender, arterial hypertension, diabetes, glomerular filtration rate and medical therapy.
Contributors

Matteo Bini
Author

Umberto Camaiora
Author

Paolo Castiglioni
Author

Luca Moderato
Author

Davide Bosi
Author

Simone Geroldi
Author

Pietro T Ugolotti
Author

Lorenzo Brambilla
Author

Valerio Brambilla
Author

Paolo Coruzzi
Author

